Status:
COMPLETED
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
Lead Sponsor:
Can Tho University of Medicine and Pharmacy
Conditions:
Acute Bronchiolitis
Eligibility:
All Genders
1-24 years
Phase:
PHASE2
PHASE3
Brief Summary
This study aims to determine the efficacy of nebulising 3% hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis.
Detailed Description
Bronchiolitis is the most prevalent disease in infants, especially children younger than two years old. Clinical manifestations vary from mild to severe, even life-threatening respiratory failure. Air...
Eligibility Criteria
Inclusion
- Pediatric patients diagnosed with acute bronchiolitis from 1 to 24 months old at Can Tho Children's Hospital.
Exclusion
- Family members do not agree to let the child participate in the study.
- Severe respiratory failure required mechanical ventilation.
- The patient left on his own during treatment.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06558461
Start Date
June 1 2022
End Date
May 28 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Can Tho Children's Hospital
Can Tho, Vietnam, 900000